Selecting the Right Tool For the Job

American Journal of Bioethics

Volumn 15, Issue 4, 2015, Pages 4-10

  Caplan, Arthur L ^a   Plunkett, Carolyn ^b   Levin, Bruce ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

adaptive trial design; cluster randomized designs; compassionate access; Ebola treatment trials; elimination of inferior treatments; expanded access; international research; placebo controls; randomized controlled trials (RCT); research ethics; selection trials; sequential designs; standard of care controls

Indexed keywords

EBOLA VIRUS;

CLINICAL TRIAL (TOPIC); EPIDEMIC; ETHICS; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMAN; HUMAN EXPERIMENT; LIBERIA; METHODOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; SIERRA LEONE; STANDARDS;

CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; ETHICS, RESEARCH; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; LIBERIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SIERRA LEONE; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 84927623055     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2015.1010993     Document Type: Article

References (27)

1. Adebamowo, C., O. Bah-Sow, F. Binka, et al. 2014. Randomised controlled trials for Ebola: Practical and ethical issues. Lancet. 384(9952): 1423–1424.
2. BBC. 2014. Ebola outbreak: Guinea health team killed. BBC News Africa September 19. Available at: http://www.bbc.com/news/world-africa-29256443
3. Bechhofer, R. E. 1954. A single-sample multiple decision procedure for ranking means of normal populations with known variances. Annals of Mathematical Statistics 25: 16–29. http://dx.doi.org/10.1214/aoms/1177728845
4. Bechhofer, R. E., T. J. Santner, and D. M. Goldsman. 1995. Design and analysis of experiments for statistical selection, screening, and multiple comparisons. New York, NY: John Wiley & Sons.
5. Boseley, S. 2014. Ebola: Experimental drug trials to go ahead in west Africa. The Guardian November 13. Available at: http://www.theguardian.com/world/2014/nov/13/ebola-drug-trials-liberia-guinea
6. Bryski, T., et al. 2012. Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Research 14(4): R110. Available at: http://dx.doi.org/10.1186/bcr3231.
7. Caplan, A., and K. Moch. 2014a. Rescue me: The challenge of compassionate use in the social media era. Health Affairs. Available at: http://healthaffairs.org/blog/2014/08/27/rescue-me-the-challenge-of-compassionate-use-in-the-social-media-era/
8. Caplan, A., and A. Zink. 2014b. Adverse event management in mass drug administration for neglected tropical disease. Clinical Therapeutics 36(3): 421–424. Available at: http://dx.doi.org/10.1016/j.clinthera.2014.02.002
9. Chen, C. 2004. Rebellion against the polio vaccine in Nigeria: Implications for humanitarian policy. African Health Sciences 4(3): 205–207.
10. Coffey, C. S., B. Levin, C. Clark, et al. 2012. Overview, hurdles, and future work in adaptive designs: Perspectives from an NIH-funded workshop. Clinical Trials 9(6): 671–680. Available at: http://dx.doi.org/10.1177/1740774512461859
11. Cohen, J., and K. Kupferschmidt 2014. Ebola vaccine trials raise ethical issues: Randomized studies may offer fastest answer. Science Magazine 346(6207): 289–290.
12. Cox, E., L. Borio, and R. Temple. 2014. Evaluating Ebola therapies—The case for RCTs. New England Journal of Medicine 371(25): 2350–2351. Available at: http://dx.doi.org/10.1056/NEJMp1414145.
13. Draguez, B. 2014. Ebola: On experimental treatments and vaccines. Doctors Without Borders: Voices From the Field. October 17. Available at: http://www.doctorswithoutborders.org/article/ebola-experimental-treatments-and-vaccines
14. Dresser, R. 2014. Subversive subjects: Rule-breaking and deception in clinical trials. Journal of Law, Medicine & Ethics 41: 829–840, Available at: http://dx.doi.org/10.1111/jlme.12093
15. Evans, R. 2011. Epidemics breed public disorder and the breakdown of trust. The Guardian May 9. Available at: http://www.theguardian.com/science/2011/may/09/epidemics-cholera-aids-trust-scientists
16. Gibbons, J. D., I. Olkin, and M. Sobel. 1977. Selecting and ordering populations. New York, NY: John Wiley & Sons.
17. Harmon, S. 2014. Ebola, polio, HIV: It's dangerous to mix healthcare and foreign policy. The Guardian August 14. Available at: http://www.theguardian.com/global-development/poverty-matters/2014/aug/14/ebola-polio-hiv-healthcare-foreign-policy
18. Hunt, A. 2014. Exponential growth in Ebola outbreak since May 14, 2014. Complexity 20(2): 8–11. Available at: http://dx.doi.org/10.1002/cplx.21615
19. Joffe, S. 2014. Evaluating novel therapies during the Ebola epidemic. Journal of the American Medical Association 312(13): 1299–1300. Available at: http://dx.doi.org/10.1001/jama.2014.12867
20. Leu, C.-S., and B. Levin. 2008. A generalization of the Levin-Robbins procedure for binomial subset selection and recruitment problems. Statistica Sinica 18: 203–218.
21. Leu, C.-S., Y.-K. Cheung, and B. Levin. 2011. Subset selection in comparative selection trials. In Recent advances in biostatistics: False discovery, survival analysis, and other topics, vol. 4, ed. M. Bhattacharjee, S. K. Dhar, and S. Subramanian, 271–288, London, UK: World Scientific.
22. Monti-Masel, J. 2014. On the science and ethical of Ebola treatments. Scientia Salon, August 14. Available at: http://scientiasalon.wordpress.com/2014/08/14/on-the-science-and-ethics-of-ebola-treatments/
23. Morin, M. 2014. FDA officials defend use of placebos during Ebola drug trials. Los Angeles Times November 5. Available at: http://www.latimes.com/science/sciencenow/la-sci-sn-ebola-tropical-20141105-story.html
24. Rid, A., and E. Emanuel. 2014. Ethical considerations of experimental interventions in the Ebola outbreak. Lancet. 384(9957): 1896–1899.
25. U.S. Food and Drug Administration. 2010. Guidance for industry—Adaptive design clinical trials for drugs and biologics. Available at: http://www.fda.gov/downloads/drugs/guidances/ucm201790.pdf
26. World Health Organization. 2014a. WHO high-level meeting on Ebola vaccines access and financing 23 October 2014, Summary report. Geneva, Switzerland. Available at: http://apps.who.int/iris/bitstream/10665/137184/1/WHO_EVD_Meet_EMP_14.2_eng.pdf?ua=1
27. World Health Organization. 2014b. Ethical issues related to study design for trials on therapeutics for Ebola Virus Disease WHO Ethics Working Group Meeting 20–21 October, Summary of discussion. Geneva, Switzerland. Available at: http://apps.who.int/iris/bitstream/10665/137509/1/WHO_HIS_KER_GHE_14.2_eng.pdf?ua=1